动物源产气荚膜梭菌对大环内酯-林可酰胺-链阳菌素的耐药模式
Macrolide-lincosamide-streptogramin resistance patterns in Clostridium perfringens from animals.
作者信息
Dutta G N, Devriese L A
出版信息
Antimicrob Agents Chemother. 1981 Feb;19(2):274-8. doi: 10.1128/AAC.19.2.274.
Abstract
Different patterns of resistance against commonly used macrolide, lincosamide, and streptogramin antibiotics were found in Clostridium perfringens of animal origin. The patterns were designated as (i) macrolide-lincosamide-streptogramin group B generalized resistance, (ii) macrolide-lincosamide generalized resistance, (iii) macrolide-lincosamide inducible resistance, and (iv) macrolide-lincosamide-streptogramin low-level generalized resistance. The strains of the fourth pattern were able to inactivate pristinamycin and virginiamycin. The macrolide-susceptible strains showed a bimodal distribution of lincomycin and clindamycin susceptibility levels. The susceptible strains were inhibited by 0.25 micrograms of lincomycin per ml and 0.03 micrograms of clindamycin per ml. The low-level resistant strains were inhibited at concentrations of 2 to 4 micrograms of lincomycin per ml and 0.5 to 2 micrograms of clindamycin per ml.
摘要
在动物源产气荚膜梭菌中发现了对常用大环内酯类、林可酰胺类和链阳菌素类抗生素的不同耐药模式。这些模式被指定为：（i）大环内酯-林可酰胺-链阳菌素B组广泛耐药；（ii）大环内酯-林可酰胺广泛耐药；（iii）大环内酯-林可酰胺诱导耐药；以及（iv）大环内酯-林可酰胺-链阳菌素低水平广泛耐药。第四种模式的菌株能够使 pristinamycin 和维吉尼亚霉素失活。大环内酯敏感菌株的林可霉素和克林霉素敏感性水平呈双峰分布。敏感菌株被每毫升0.25微克的林可霉素和每毫升0.03微克的克林霉素抑制。低水平耐药菌株在每毫升2至4微克林可霉素和每毫升0.5至2微克克林霉素的浓度下被抑制。
相似文献
1
Macrolide-lincosamide-streptogramin resistance patterns in Clostridium perfringens from animals.动物源产气荚膜梭菌对大环内酯-林可酰胺-链阳菌素的耐药模式
Antimicrob Agents Chemother. 1981 Feb;19(2):274-8. doi: 10.1128/AAC.19.2.274.
2
3
Macrolide, lincosamide and streptogramin resistance in Campylobacter jejuni/coli.空肠弯曲菌/结肠弯曲菌对大环内酯类、林可酰胺类和链阳菌素的耐药性
J Antimicrob Chemother. 1986 Mar;17(3):315-21. doi: 10.1093/jac/17.3.315.
4
Cloning and sequence analysis of ermQ, the predominant macrolide-lincosamide-streptogramin B resistance gene in Clostridium perfringens.产气荚膜梭菌中主要的大环内酯-林可酰胺-链阳菌素B抗性基因ermQ的克隆与序列分析
Antimicrob Agents Chemother. 1994 May;38(5):1041-6. doi: 10.1128/AAC.38.5.1041.
5
Resistance to macrolide, lincosamide and streptogramin antibiotics and degradation of lincosamide antibiotics in streptococci from bovine mastitis.牛乳腺炎链球菌对大环内酯类、林可酰胺类和链阳菌素类抗生素的耐药性以及林可酰胺类抗生素的降解
J Antimicrob Chemother. 1982 Nov;10(5):403-8. doi: 10.1093/jac/10.5.403.
6
Occurrence of macrolide-lincosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center. Is false susceptibility to new macrolides and clindamycin a contemporary clinical and in vitro testing problem?某大学医学中心葡萄球菌临床分离株中大环内酯-林可酰胺-链阳菌素耐药性的出现。对新型大环内酯类药物和克林霉素的假敏感性是当代临床和体外检测的问题吗？
Diagn Microbiol Infect Dis. 1993 Mar-Apr;16(3):205-13. doi: 10.1016/0732-8893(93)90111-j.
7
A family of r-determinants in Streptomyces spp. that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibiotics.链霉菌属中的一个r-决定簇家族，它决定了对大环内酯类、林可酰胺类和B型链阳菌素类抗生素的诱导抗性。
J Bacteriol. 1981 May;146(2):621-31. doi: 10.1128/jb.146.2.621-631.1981.
8
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).一种酮内酯（HMR 3647）、一种链阳菌素（奎奴普丁-达福普汀）、一种大环内酯（红霉素）和一种林可酰胺（克林霉素）的抗肺炎球菌活性。
Antimicrob Agents Chemother. 1998 Apr;42(4):945-6. doi: 10.1128/AAC.42.4.945.
9
Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. III. Novel, inducible resistance to macrolide-lincosamide-streptogramin B (MLS) antibiotics.耐甲氧西林金黄色葡萄球菌临床分离株对多种抗菌药物的敏感性。III. 对大环内酯-林可酰胺-链阳菌素B（MLS）抗生素的新型诱导性耐药
Hiroshima J Med Sci. 1993 Sep;42(3):101-7.
10
Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.希腊雅典一家三级护理医院葡萄球菌中大环内酯类、林可酰胺类和链阳菌素耐药性的流行情况
J Chemother. 2015;27(6):319-23. doi: 10.1179/1973947814Y.0000000205. Epub 2014 Aug 11.
引用本文的文献
1
Biofilm formation, antimicrobial assay, and toxin-genotypes of Clostridium perfringens type C isolates cultured from a neonatal Yangtze finless porpoise.从长江江豚新生儿分离的 C 型产气荚膜梭菌的生物膜形成、抗菌测定和毒素基因型。
Arch Microbiol. 2022 Jun 4;204(7):361. doi: 10.1007/s00203-022-02990-y.
2
Prevalence, toxin gene profile, antibiotic resistance, and molecular characterization of from diarrheic and non-diarrheic dogs in Korea.韩国腹泻和非腹泻犬的患病率、毒素基因谱、抗生素耐药性及分子特征
J Vet Sci. 2018 May 31;19(3):368-374. doi: 10.4142/jvs.2018.19.3.368.
3
Susceptibility of fecal streptococci of poultry origin to nine growth-promoting agents.家禽源粪链球菌对九种促生长剂的敏感性。
Appl Environ Microbiol. 1982 Oct;44(4):832-7. doi: 10.1128/aem.44.4.832-837.1982.
4
Evolutionary relationships of the Bacillus licheniformis macrolide-lincosamide-streptogramin B resistance elements.地衣芽孢杆菌大环内酯-林可酰胺-链阳菌素B抗性元件的进化关系。
Mol Gen Genet. 1984;194(3):362-7. doi: 10.1007/BF00425545.
5
Plasmid-mediated high-level resistance to erythromycin in Escherichia coli.大肠杆菌中质粒介导的对红霉素的高水平抗性
Antimicrob Agents Chemother. 1986 Mar;29(3):515-8. doi: 10.1128/AAC.29.3.515.
6
Novel mechanisms of resistance to lincosamides in Staphylococcus and Arthrobacter spp.葡萄球菌属和节杆菌属中对林可酰胺类药物耐药的新机制
Antimicrob Agents Chemother. 1988 Apr;32(4):420-5. doi: 10.1128/AAC.32.4.420.
7
Cloning and hybridization analysis of ermP, a macrolide-lincosamide-streptogramin B resistance determinant from Clostridium perfringens.产气荚膜梭菌大环内酯-林可酰胺-链阳菌素B耐药决定因子ermP的克隆与杂交分析
Antimicrob Agents Chemother. 1989 Aug;33(8):1346-53. doi: 10.1128/AAC.33.8.1346.
8
Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria.细菌对大环内酯类、林可酰胺类和链阳菌素类抗生素的内在及异常耐药性。
Antimicrob Agents Chemother. 1991 Jul;35(7):1273-6. doi: 10.1128/AAC.35.7.1273.
9
Molecular genetics and pathogenesis of Clostridium perfringens.产气荚膜梭菌的分子遗传学与发病机制
Microbiol Rev. 1991 Dec;55(4):621-48. doi: 10.1128/mr.55.4.621-648.1991.
本文引用的文献
1
THE DETECTION OF PENICILLINASE-PRODUCING PROPERTIES OF MICROORGANISMS.产青霉素酶微生物特性的检测
Science. 1945 Sep 21;102(2647):309. doi: 10.1126/science.102.2647.309.
2
INDUCIBLE RESISTANCE TO ERYTHROMYCIN IN STAPHYLOCOCCUS AUREUS.金黄色葡萄球菌对红霉素的诱导抗性
J Bacteriol. 1964 Sep;88(3):574-80. doi: 10.1128/jb.88.3.574-580.1964.
3
ANTIBACTERIAL ACTIVITY OF LINCOMYCIN AND PRISTINAMYCIN: A COMPARISON WITH ERYTHROMYCIN.林可霉素和普那霉素的抗菌活性：与红霉素的比较
Br Med J. 1964 Sep 5;2(5409):603-6. doi: 10.1136/bmj.2.5409.603.
4
The erythromycin group of antibiotics.红霉素类抗生素。
Br Med J. 1957 Jul 13;2(5036):57-63. doi: 10.1136/bmj.2.5036.57.
5
[In vitro antagonism between erythromycin and spiramycin].[红霉素与螺旋霉素的体外拮抗作用]
Ann Inst Pasteur (Paris). 1956 Jun;90(6):787-90.
6
[Effect of rythromycin on the growth of "dissociated resistant" Staph. aureus in bacteriostasis from another macrolide or a related antibiotic].
Ann Inst Pasteur (Paris). 1967 Jul;113(1):67-79.
7
Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved.金黄色葡萄球菌中红霉素诱导的耐药性：涉及抗生素类别的调查
J Bacteriol. 1969 May;98(2):447-52. doi: 10.1128/jb.98.2.447-452.1969.
8
Resistance of some species of Clostridium to clindamycin.某些梭菌属物种对克林霉素的耐药性。
Antimicrob Agents Chemother. 1973 Jan;3(1):136-7. doi: 10.1128/AAC.3.1.136.
9
Determination of bacterial susceptibility to tylosin by single-disk agar diffusion tests.
Am J Vet Res. 1974 Dec;35(12):1563-5.
10
Inducible and constitutive resistance to macrolide antibiotics and lincomycin in clinically isolated strains of Streptococcus pyogenes.化脓性链球菌临床分离株对大环内酯类抗生素和林可霉素的诱导性及固有耐药性
Antimicrob Agents Chemother. 1973 Sep;4(3):327-31. doi: 10.1128/AAC.4.3.327.
Zotero 插件